Decline in eGFR over time and incidence of cardiovascular events: Shinken database analysis |
| |
Authors: | Tomoki Fujisawa Shinya Suzuki Takuto Arita Naoharu Yagi Takayuki Otsuka Hiroto Kano Shunsuke Matsuno Hiroaki Semba Yuko Kato Tokuhisa Uejima Yuji Oikawa Minoru Matsuhama Junji Yajima Takeshi Yamashita |
| |
Institution: | 1. Department of Cardiovascular Medicine, The Cardiovascular Institute, Tokyo, Japan;2. Department of Cardiovascular Surgery, The Cardiovascular Institute, Tokyo, Japan |
| |
Abstract: | BackgroundIt has been reported that a large decline in estimated glomerular filtration rate (eGFR) over time is associated with increased incidence of cardiovascular disease. We investigated whether this association differs according to the baseline eGFR.MethodsA total of 4666 patients (male 71%) with measurements of eGFR at both baseline and 1 year and that had no cardiovascular events at 1-year follow-up were retrieved from the Shinken Database between June 2004 and March 2015. The study population was divided into three groups by baseline eGFR (mL/min/1.73 m2): high (≥60, n = 1650), intermediate (45–59, n = 1947), and low (<45, n = 1069) eGFR groups. Each eGFR group was further divided into two groups by eGFR slope (change at 1 year, <-10 and ≥-10 mL/min/1.73 m2). The patient characteristics and the incidences of cardiovascular events within 3 years (after 1-year follow-up) were compared between the negatively large eGFR slope (<-10) and others (≥-10) in each eGFR group.ResultsA total of 187 cardiovascular events occurred during the mean follow-up of 2.8 ± 0.6 years. The adjusted hazard ratios of eGFR slope (<-10 with reference to ≥-10) were 2.37 (95% CI, 1.28–4.40), 3.10 (95% CI, 1.78–5.40), and 2.66 (95% CI, 1.15–6.13) in the high, middle, and low eGFR groups, respectively. Similar results were found in patients with structural heart disease, but not in those without.ConclusionsDecline in eGFR was associated with an increase in cardiovascular events, and this effect was consistent regardless of the baseline eGFR. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|